Celldex Therapeutics shares owned by Vanguard Portfolio Management
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Vanguard Portfolio Management
from 13F filings
Historical chart of Vanguard Portfolio Management investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Vanguard Portfolio Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Vanguard Portfolio Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $20M | 629k | 31.72 |
More positions owned by Vanguard Portfolio Management
View all positions for Vanguard Portfolio Management